Nuevitas, Oct 25.- Is foresaw the use of the HeberFERON, in units of Health of Nuevitas, medicine produced in Cuba for the treatment of the complained persons with cancer of skin cellspleen.
It pretends to arrive to the patients amog that what remain of the present year and the 2020, as part of the strategy in order to enlarge its utilization on the primary level of the sector in the Camagüey province, according to with information of the Cuban Agency of Notices published on the web place of the Adelante newspaper.
Two years ago of the medicament’s application on the principals hospitable institutions of the Camagüey city, and resulted the policlinic Sur of the municipality of Florida the first on integrate it self to the National Program of Extension of the product commented Mérida Jiménez Lamas to the communication medae, her coordinator on the territory
Until assitance institutions of Guáimaros and others two put in a place at the Tinajon city it will extend the HerberFERON use in similar period than Nuevitas, the Dermatology specialist pointed out
With the medicine unique of its kind to the confronting of the celspleen carcinoma, the cutaneo tumour on the world more frequent, in the two years were benefited little more than 150 peoples of Camagüey, 86 of them with complete reply to the treatment, the Cuban Agency of Notices indicates
In 2018 the province was the second on to register the best result of that indicator, then more than 40 patients maintained the totla disapearance of the lesinons, after the evaluation which it carrys out to the 16 weeks of the HeberFERON.
Since last january and until the date are are adding something more than 60 the protect sicks with the product in the Oncologico hospitals Marie Curie and Clinic Chirurgical Amalia Simoni, though the service it offers equally in the Universitary Manuel Ascunce Domenech Hospital.
The therapeutic alternative, developed at the Institution of Genetic Ingineering and Biotechnology of the Havana, retards the tumour increase and eliminate the CBC *( cuban term) of any subkind, size and location.
As others of theirs kindness exceed the lengthening of the reply to the treatment at least unit five years and the frequency’s reduction of apparition of news lesion and the performance of surgerys on complex locations, include the publication.
